Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Incyte Corporation (INCY)

« Back to company index

INCY Chatter Timeline

Stock Ticker for INCY

Most Active Tweeters for INCY

UserTweets
@Tickeron 12
@AmericanBanking 10
@Gambiste1 7
@DataTrials 5
@IBD_AGatlin 5

Recent Tweets for INCY

dailypoliticaln @dailypoliticaln
Zacks: Analysts Expect Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/u3Pw2YRFXj
12:01pm
tradersreport @tradersreport
RT @Tickeron: $INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.…
9:01am
Tickeron @Tickeron
$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators:… https://t.co/3IvfJsfqbx
9:01am
ConsumerFeed @ConsumerFeed
Incyte $INCY Rating Reiterated by Cantor Fitzgerald https://t.co/TJZ3Y1nUwa
7:01am
dailypoliticaln @dailypoliticaln
Incyte $INCY Rating Reiterated by Cantor Fitzgerald https://t.co/LsM3bpSIhs
7:01am
AmericanBanking @AmericanBanking
Incyte $INCY Given Neutral Rating at Cantor Fitzgerald https://t.co/7hUoe4sQNH #stocks
7:01am
MelStone31 @MelStone31
$INCY - Cantor raises PT to $83 ~ reiterates neutral rating https://t.co/LkgTEj0JK4
7:01am
briansutcliffe1 @briansutcliffe1
@chiragontwtr @JD4myfab4 Plus risk to $INCY now is lose on judicial appeal. We know judges are more proficiently se… https://t.co/bF7cFnUDCX
January 22nd 2020, 9:01pm
briansutcliffe1 @briansutcliffe1
@chiragontwtr @JD4myfab4 What I was thinking as well. $INCY must challenge new patent which of course is process
January 22nd 2020, 8:01pm
tq_equities @tq_equities
$INCY unable to break through key resistance level: https://t.co/iXeOfl9L80 Sentiment: Slightly bearish #INCY #Incyte
January 22nd 2020, 5:01pm
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $INCY https://t.co/V2KZZEES8h
January 22nd 2020, 4:01pm
SeasonalEdge @SeasonalEdge
Today's insight on $INCY https://t.co/lD3MHUHNcT https://t.co/a7E8LjjQ2h
January 22nd 2020, 4:01pm
InsiderAlertsIA @InsiderAlertsIA
$INCY: New Insider Filing on EVP, Head of Discovery Chem YAO WENQING: https://t.co/SeXKnzzExJ
January 22nd 2020, 4:01pm
StockTexts @StockTexts
$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/Vq2UeKqLIe
January 22nd 2020, 4:01pm
Tickeron @Tickeron
$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/7fxnymD5yr
January 22nd 2020, 10:01am
bbnsnews @bbnsnews
Incyte Co. $INCY Expected to Post Quarterly Sales of $569.75 Million https://t.co/dRn84nZtEK
January 22nd 2020, 2:01am
AmericanBanking @AmericanBanking
Zacks: Analysts Expect Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/1Fw9XoOlUZ #stocks
January 22nd 2020, 2:01am
Tickeron @Tickeron
$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/TSL3oWrH5o
January 21st 2020, 8:01am
dispatchtribune @dispatchtribune
Incyte Co. $INCY Receives Consensus Rating of “Hold” from Analysts https://t.co/wspt4jMYDA
January 20th 2020, 6:01pm
OlympiaReport @OlympiaReport
Incyte Co. $INCY Receives Average Rating of “Hold” from Brokerages https://t.co/5aNxeUCT4B
January 20th 2020, 6:01pm
Finscreener_com @Finscreener_com
Financials of #Incyte #INCY $INCY https://t.co/Exsy3FikDe
January 20th 2020, 4:01pm
Dorahc22 @Dorahc22
$INCY looking for break, 200MA could cause strong resistance and push back down https://t.co/ko633lUbD4
January 20th 2020, 11:01am
AmericanBanking @AmericanBanking
$0.58 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/Ui9c2tbd7a #stocks
January 20th 2020, 8:01am
bbnsnews @bbnsnews
Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/oNPvrQzt56
January 20th 2020, 8:01am
Tickeron @Tickeron
$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/EZ2VLnDFYq
January 20th 2020, 8:01am
bbnsnews @bbnsnews
Insider Selling: Incyte Co. $INCY EVP Sells 2,500 Shares of Stock https://t.co/Rct7NxBvdE
January 20th 2020, 5:01am
TickerReport @TickerReport
Insider Selling: Incyte Co. $INCY EVP Sells $202,800.00 in Stock https://t.co/3QQ3c7o8gd
January 20th 2020, 4:01am
AmericanBanking @AmericanBanking
Analysts’ Recent Ratings Changes for Incyte $INCY https://t.co/SL6UCjWJIU #stocks
January 20th 2020, 3:01am
Tickeron @Tickeron
$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/qS0XffFiXc
January 19th 2020, 8:01am
ZolmaxNews @ZolmaxNews
Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/UMdBwf6c7O
January 19th 2020, 5:01am
newsfilterio @newsfilterio
SevenBridge Financial Group Purchases New Shares in Incyte $INCY https://t.co/5oWQp9f7ES
January 18th 2020, 6:01pm
newsfilterio @newsfilterio
Incyte Receives “Outperform” Rating from JMP Securities $INCY https://t.co/VqthchJNHg
January 18th 2020, 2:01pm
dailypoliticaln @dailypoliticaln
Brokerages Set Incyte Co. $INCY Target Price at $92.10 https://t.co/oeFpaKppNe
January 18th 2020, 12:01pm
stocknewstimes @stocknewstimes
Incyte $INCY Receives “Outperform” Rating from JMP Securities https://t.co/lDaBnyA0QH
January 18th 2020, 11:01am
TranscriptDaily @TranscriptDaily
Incyte $INCY Receives “Outperform” Rating from JMP Securities https://t.co/43oMMIWris
January 18th 2020, 11:01am
Tickeron @Tickeron
$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/Y7m7UWltU5
January 18th 2020, 9:01am
WatchlistN @WatchlistN
Incyte Co. $INCY EVP Sells $202,800.00 in Stock https://t.co/z6gGDh89bv
January 18th 2020, 8:01am
ConsumerFeed @ConsumerFeed
Incyte Co. $INCY EVP Paula J. Swain Sells 2,500 Shares https://t.co/dupggitxlM
January 18th 2020, 7:01am
dispatchtribune @dispatchtribune
Incyte’s $INCY “Outperform” Rating Reiterated at JMP Securities https://t.co/pW5CIeRICB
January 17th 2020, 7:01pm
OlympiaReport @OlympiaReport
JMP Securities Reaffirms “Outperform” Rating for Incyte $INCY https://t.co/c8hwc7OcSD
January 17th 2020, 7:01pm
WatchlistN @WatchlistN
Incyte’s $INCY “Buy” Rating Reaffirmed at JPMorgan Chase & Co. https://t.co/O0FqEOf166
January 17th 2020, 7:01pm
ConsumerFeed @ConsumerFeed
JPMorgan Chase & Co. Reaffirms “Buy” Rating for Incyte $INCY https://t.co/lielwFAbuS
January 17th 2020, 7:01pm
WeekHerald @WeekHerald
Incyte Co. $INCY EVP Sells $202,800.00 in Stock https://t.co/yITBBEKDfW
January 17th 2020, 6:01pm
AmericanBanking @AmericanBanking
Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/Kz6Vgt0tB4 #stocks
January 17th 2020, 6:01pm
OlympiaReport @OlympiaReport
Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/ealSc9StMm
January 17th 2020, 6:01pm
MonitorAction @MonitorAction
$INCY Paula Swain Dumps 2.5K Shares of Incyte https://t.co/l7uiY6tqlM
January 17th 2020, 4:01pm
InsiderAlertsIA @InsiderAlertsIA
$INCY: New Insider Filing on EVP, Human Resources PAULA J SWAIN: https://t.co/m5LllMqaVS
January 17th 2020, 4:01pm
StockTexts @StockTexts
$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/fnvK81yOTY
January 17th 2020, 4:01pm
tradersreport @tradersreport
RT @Tickeron: $INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/9rJ…
January 17th 2020, 9:01am
Tickeron @Tickeron
$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/NWsb6rQGNN
January 17th 2020, 9:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.